Cargando…
Clinicopathological characteristics and MYC status determine treatment outcome in plasmablastic lymphoma: a multi-center study of 76 consecutive patients
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260224/ https://www.ncbi.nlm.nih.gov/pubmed/32471974 http://dx.doi.org/10.1038/s41408-020-0327-0 |
| _version_ | 1783540272628498432 |
|---|---|
| author | Witte, Hanno M. Hertel, Nadine Merz, Hartmut Bernd, Heinz-Wolfram Bernard, Veronica Stölting, Stephanie von Bubnoff, Nikolas Feller, Alfred C. Gebauer, Niklas |
| author_facet | Witte, Hanno M. Hertel, Nadine Merz, Hartmut Bernd, Heinz-Wolfram Bernard, Veronica Stölting, Stephanie von Bubnoff, Nikolas Feller, Alfred C. Gebauer, Niklas |
| author_sort | Witte, Hanno M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7260224 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72602242020-06-10 Clinicopathological characteristics and MYC status determine treatment outcome in plasmablastic lymphoma: a multi-center study of 76 consecutive patients Witte, Hanno M. Hertel, Nadine Merz, Hartmut Bernd, Heinz-Wolfram Bernard, Veronica Stölting, Stephanie von Bubnoff, Nikolas Feller, Alfred C. Gebauer, Niklas Blood Cancer J Correspondence Nature Publishing Group UK 2020-05-29 /pmc/articles/PMC7260224/ /pubmed/32471974 http://dx.doi.org/10.1038/s41408-020-0327-0 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Witte, Hanno M. Hertel, Nadine Merz, Hartmut Bernd, Heinz-Wolfram Bernard, Veronica Stölting, Stephanie von Bubnoff, Nikolas Feller, Alfred C. Gebauer, Niklas Clinicopathological characteristics and MYC status determine treatment outcome in plasmablastic lymphoma: a multi-center study of 76 consecutive patients |
| title | Clinicopathological characteristics and MYC status determine treatment outcome in plasmablastic lymphoma: a multi-center study of 76 consecutive patients |
| title_full | Clinicopathological characteristics and MYC status determine treatment outcome in plasmablastic lymphoma: a multi-center study of 76 consecutive patients |
| title_fullStr | Clinicopathological characteristics and MYC status determine treatment outcome in plasmablastic lymphoma: a multi-center study of 76 consecutive patients |
| title_full_unstemmed | Clinicopathological characteristics and MYC status determine treatment outcome in plasmablastic lymphoma: a multi-center study of 76 consecutive patients |
| title_short | Clinicopathological characteristics and MYC status determine treatment outcome in plasmablastic lymphoma: a multi-center study of 76 consecutive patients |
| title_sort | clinicopathological characteristics and myc status determine treatment outcome in plasmablastic lymphoma: a multi-center study of 76 consecutive patients |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260224/ https://www.ncbi.nlm.nih.gov/pubmed/32471974 http://dx.doi.org/10.1038/s41408-020-0327-0 |
| work_keys_str_mv | AT wittehannom clinicopathologicalcharacteristicsandmycstatusdeterminetreatmentoutcomeinplasmablasticlymphomaamulticenterstudyof76consecutivepatients AT hertelnadine clinicopathologicalcharacteristicsandmycstatusdeterminetreatmentoutcomeinplasmablasticlymphomaamulticenterstudyof76consecutivepatients AT merzhartmut clinicopathologicalcharacteristicsandmycstatusdeterminetreatmentoutcomeinplasmablasticlymphomaamulticenterstudyof76consecutivepatients AT berndheinzwolfram clinicopathologicalcharacteristicsandmycstatusdeterminetreatmentoutcomeinplasmablasticlymphomaamulticenterstudyof76consecutivepatients AT bernardveronica clinicopathologicalcharacteristicsandmycstatusdeterminetreatmentoutcomeinplasmablasticlymphomaamulticenterstudyof76consecutivepatients AT stoltingstephanie clinicopathologicalcharacteristicsandmycstatusdeterminetreatmentoutcomeinplasmablasticlymphomaamulticenterstudyof76consecutivepatients AT vonbubnoffnikolas clinicopathologicalcharacteristicsandmycstatusdeterminetreatmentoutcomeinplasmablasticlymphomaamulticenterstudyof76consecutivepatients AT felleralfredc clinicopathologicalcharacteristicsandmycstatusdeterminetreatmentoutcomeinplasmablasticlymphomaamulticenterstudyof76consecutivepatients AT gebauerniklas clinicopathologicalcharacteristicsandmycstatusdeterminetreatmentoutcomeinplasmablasticlymphomaamulticenterstudyof76consecutivepatients |